Our results show that MYCN acts as an oncogene in RB1-proficient retinas, leading to neoplasia in two novel models of retinoblastoma: one with MYCN over-expression in the chicken retina and one in hESC-derived retinal organoids. The gene discussed is MYCN; the disease is neoplasm.